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Introduction
STC-1 and pGIP/Neo cell lines were seeded in 24-well plates at a density of 2 x 10 5 /well and incubated 126 in a 5% CO2 humidified atmosphere at 37 o C overnight. Media was removed and 1 ml of fresh media 127 added to each well and cells were incubated as above for 72h upon which the media was collected, 128 centrifuged to remove cellular debris and stored at -80 o C prior to ELISA analysis. 129
To assess the cellular hormone content acid/Ethanol (1.5% v/v HCl, 75% v/v ethanol, 23.5% v/v H2O) 130 was added and incubated overnight at 4 o C. The incubation solution was removed and centrifuged 131 prior to adding to cells and protected from the light after preparation. Cells were seeded into 96-well 141 plates (5 x 10 4 per well) and cultured overnight at 37 °C in a humidified atmosphere of 5% CO2. Media 142 was removed and cells fixed with 10% formalin for 10 min at room temperature. Cells were washed 143 (x4) with PBS and permeabilisation solution added and incubated for 30 min at room temperature. 144
Again, cells were washed (x4) with PBS before blocking solution (0.3 M glycine + 10% goat serum in 145 1% BSA in PBST (PBS + 0.01% Tween 20) was added for a further 1h. The blocking solution was 146 removed and the GLP-1, GIP, CCK or PYY antibody was added (1:200 dilution) and allowed to incubate 147 overnight. Supernatant was removed and cells were washed with PBS (3 times x 5 min) in the dark, 148 after which Hoechst staining solution (Thermo Scientific, Hampstead, UK) was added for 10 min. Cells 149 were washed with PBS (x1) and PBS added to each well and the plate was sealed prior to reading using 150 the ArrayScan  HCS Reader (Thermo, Loughborough, UK). The plate was evaluated at absorbance 350-151 461 nm and 485-520 nm for Hoechst dye and antibody fluorescence, respectively. Typical micrographs 152 obtained from the ArrayScan  system can be found in Figure 1 . 153 154
HCA software parameters 155
We determined the percentage of cells with immunoreactivity to GLP-1, GIP, PYY or CCK by application 156 of the HCS Studio Cell Analysis Software (Thermo Scientific, Hampstead, UK). Parameters from the 157 results database each individual cell were queried by applying the appropriate conditions e.g. GLP-1 158 only, AND NOT GIP, NOT CCK and NOT PYY (to find cells immunoreactive to GLP-1 ONLY). 159
This was carried out in a similar manner for each hormone and combination of hormones. The 160 percentage of immunoreactive cells was then calculated for each well. For the in-depth analysis of 161 GIP immunoreactive cells, reference values were set and values that fell above the lowest quartile but 162 below the highest quartile were determined to be 'with-in range'. Values with immunoreactivity in 163 the highest quartile were classified as 'High immunoreactivity', whereas immunoreactivity values in 164 the lowest quartile were classified as 'low immunoreactivity'.
Cells classified as 'low 165 immunoreactivity' were analysed manually to determine the percentage of these cells with 'zero 166 immunoreactivity'. 167
Gene expression 168
Cells were seeded at a density of 1 x 10 6 per well for each cell line and incubated at 5% CO2 humidified 169 atmosphere at 37 o C overnight. RNA was extracted using the High Pure Isolation Kit Version 12 (Roche 170 GGACTGGACTCTGACCTTAGC-'3 and 5'-GGCTTTATTGGTTTGGTTCTCTC-'3 and conditions were 95 o C for 179 10 min, then 50 cycles of 95 o C for 15 s and 60 o C for 60 s. PYY: 5'-GGACGCCTACCCTGCCAAACCA-'3 and 180 5'-AGTGCCCTCTTCTTAAACCAAACA-'3 and conditions were 95 o C for 10 min, followed by 40 cycles of 181 The genes were quantified by the principles of absolute quantification. A standard curve for each 193 gene was generated by purifying the relevant PCR product using QIAquick PCR Purification Kit (Qiagen, 194 Manchester, UK) and quantified on the Nanodrop 8000. The following equations used to determine 195 the number of molecules present: X g/μL DNA / [plasmid length in base pairs or length of PCR products 196
x 660]) x 6.022 x 10 23 = Y molecules/μL. A standard curve was generated by dilution of the purified PCR 197 product in nuclease-free water to obtain 2.0 x 10 8 molecules/µL and 10-fold serial dilutions carried 198 out to obtain standards ranging from 2.0 x 10 7 to 2.0 x 10 0 molecules/µL. Standards were run along 199 with the samples from each cell line and the number of molecules in each sample was determined. 200
The 18s gene was also quantified in the same manner and used as a reference gene. qRT-PCR 201 experiments were carried out using the Eppendorf MasterCycler Realplex (Rotselaar, Belgium). 202 203 2.7 Metabolomics quantify 187 metabolites including amino acids, acylcarnitines, phospho-and sphingolipids, hexose 208 (glucose), and biogenic amines. Briefly, 10 μL of culture medium was applied to a 96-well plate 209 containing isotopic internal standards. Amino acids and biogenic amines were derivatized using 210 phenylisothiocyanate (PITC) before analysis and extracted with 5 mmol/l ammonium acetate in 211 methanol. Amino acids and biogenic amines were analysed by UPLC-MS in the multiple reaction 212 monitoring (MRM) mode. The concentrations of metabolites were expressed as µmol/L. 213 214
Statistical Analysis 215
Results were expressed as means ±SEM. Data were compared using the unpaired Student's t-test. 216
Groups were considered to be significantly different if p˂0.05 (*P≤0.05; **P≤0.01; ***P≤0.001). 217
Results 218

Media accumulation and cellular content of GLP-1 and GLP-2 in cell lines 219
Quantitative measurements of total GLP-1 found that STC-1 progenitor cells accumulated significantly 220 more GLP-1 in the media than pGIP/Neo cells (72h; 1.7-fold; P≤0.01). Total cellular GLP-1 content was 221 also significantly greater in STC-1 cells than pGIP/Neo cells (2.5-fold; P≤0.05) ( Figure 2A ). GLP-2, the 222 other major preproglucagon product exhibited a similar trend. The progenitor STC-1 cell line displayed 223 greater GLP-2 media accumulation (72h; 2.4-fold; P≤0.001) and greater cellular GLP-2 content (2.5-224 fold, P≤0.001) than the pGIP/Neo cell line ( Figure 2B ). 225
Morphometric differences between STC-1 and pGIP/Neo cell lines 226
HCA detected modest but significant morphometric differences between STC-1 and pGIP/Neo cell 227 lines in terms of nuclei size, nuclei shape, and intensity nuclei (Hoechst) staining. All parameters were 228 significantly greater in pGIP/Neo cells (Nuclei size: 1.02-fold, P≤0.01, shape: 1.003-fold, P≤0.05; 229 fluorescence intensity: 1.1-fold, P≤0.001, Figure 3 ). 230
GLP-1, GIP, PYY and CCK immunoreactivity in STC-1 and pGIP/Neo cell lines 231
GLP-1 immunoreactivity was significantly greater in the STC-1 cell line (1.7-fold; P≤0.001) ( Figure 4A ) 232 whereas GIP immunoreactivity was greatest in the pGIP/Neo cell line (1.6-fold; P≤0.001) ( Figure 4B ). 233
There appeared to be a trend of increased PYY (1.4-fold) ( Figure 4C ) and CCK (1.1-fold) ( Figure 4D ) 234 levels in the pGIP/Neo cell line but neither of these were significantly different.
The levels of gene transcripts for hormones differed between the cell lines. The mRNA copy number 237 for the proglucagon gene expression (4.1-fold; P≤0.001; Figure 5A ) and the PYY gene (5.3-fold; 238 P≤0.001; Figure 5C ) were significantly higher in the pGIP/Neo cell line than the STC-1 cell line. 239
Contrastingly, the mRNA copy number for the GIP gene (47.2-fold; P≤0.001; Figure 5B ) and the CCK 240 gene (2.7-fold; P≤0.001; Figure 5D ) was significantly higher in the STC-1 cell line than the pGIP/Neo 241 cell line. The levels of gene transcripts for proteins involved in posttranslational processing also 242 differed between the cell lines. E2D2 (a ubiquitin-conjugating enzyme) and the Prohormone 243
Convertase 3 gene (PC3) had higher mRNA copy numbers in the pGIP/neo cell line, increased by 1.8-244 fold and 1.7-fold (P≤0.01; Figure 5E & 5F), respectively. 245
Hormone immunoreactivity profiles of STC-1 and pGIP/Neo cells 246
The percentage (%) of cells classified as 'GLP-1 only', 'PYY only' or 'CCK only' did not significantly differ 247 between STC-1 and pGIP/Neo cell lines ( Figure 6A & 6C) . In contrast, the % of cells classified with 'GIP 248 only' immunoreactivity was significantly higher in the pGIP/Neo cell line (3.5-fold; P≤0.05). Similarly, 249 the % of cells which co-produced GLP-1+GIP, and GIP+PYY was significantly higher (2.5-fold (P≤0.01) 250 and 1.3-fold (P≤0.05), respectively; Figure 6A ) but not for GIP+CCK ( Figure 6C ). There were no 251 significant differences in the % of STC-1 and pGIP/Neo cells co-producing GLP-1+PYY ( Figure 6A ), 252 however with pGIP/Neo cells there were significantly more GLP-1+CCK co-producing cells (1.8-fold; 253 P≤0.01; Figure 6C ). The % of cells with no immunoreactivity for the hormones tested ('Undefined') 254 did not differ between the cell lines either when they were co-stained for PYY or co-stained for CCK. 255
Differences in GIP immunoreactivity between STC-1 and pGIP/Neo cell lines 256
The increased immunoreactivity of the pGIP/Neo cell line was probed in more detail by examining 257 overall proportion of cells with low, within range and high GIP immunoreactivity. The % of cells with 258 'GIP within range' immunoreactivity did not significantly differ between the STC-1 and pGIP/Neo cell 259 lines ( Figure 7A ). However there were significantly fewer pGIP/Neo cells with 'Low GIP 260 immunoreactivity' (1.6-fold; P≤0.001; Figure 7A ), and at the same time there were significantly more 261 cells of 'High GIP immunoreactivity' (2.1-fold, P ≤ 0.01). Of the cells classified with 'Low GIP 262 immunoreactivity' 56-70% of these contained no GIP immunoreactivity at all, but did not significantly 263 differ between STC-1 and pGIP/Neo cell lines ( Figure 7B ). Overall, approximately 65% of STC-1 cells 264 and 82% of pGIP/Neo had GIP immunoreactivity (P≤0.01). 265
LC-MS metabolite profiling of cultured media from STC-1 and pGIP/Neo cells 266
For both the STC-1 and pGIP/Neo cells the culture media levels of 187 metabolites were measured 267 before and after 72h of culturing. Of the 187 metabolites only 30 were found at measurable levels in 268 media. The levels of phenylalanine, threonine, ADMA, creatinine, kynurenine, Met-SO and SDMA did 269 not differ before and after culture in either cell line. The metabolite which most dramatically changed 270 following the period of culture was Pro which increased by 724% (P≤0.001; Supplementary Table 1) We have demonstrated that the secretion of GIP's sister hormone, GLP-1 is substantially 298 greater in progenitor STC-1 cells than the sub-clone cells. Around 41% less accumulated in pGIP/Neo 299 cell media over 72h. This finding was corroborated by quantitative measurement of intracellular GLP-we were then able to probe relative levels of enteroendocrine hormones and assess their co-303 localisations within individual cells. Once again this confirmed comparatively higher GLP-1-304 immunoreactivity in progenitor STC-1 cells. Proglucagon gene expression was also assessed in both 305 cell lines, but expression was much greater in pGIP/Neo STC-1 cells, not the progenitor cells. As these 306 findings were entirely contrary to the quantitative peptide measurements and HCA data we re-307 checked this several times even developing a qRT-PCR measuring the number of proglucagon mRNA 308 transcripts. Following translation the proglucagon is processed to form GLP-1 by prohormone 309 convertase 3 (PC3 or sometimes referred to as PC1). We assessed PC3 gene expression and we 310 quantified another proglucagon-derived peptide GLP-2 to check the discrepancy in proglucagon mRNA 311 and GLP-1 peptides. We found that in a manner similar to GLP-1 both GLP-2 media accumulation and 312 intracellular storage (as assessed quantitatively by ELISA) were significantly greater in the progenitor 313 STC-1 cell line. However, mRNA copy numbers of PC3 were significantly higher in pGIP/Neo STC-1 cells. 314
This demonstrates that there is no direct correlation between the number of proglucagon mRNA 315 copies and the actual abundance of GLP-1 and GLP-2 peptides. Therefore when studying the biology 316 of enteroendocrine cells hormone mRNA and peptide measurements should be viewed as 317 complimentary (Greenbaum et al., 2003) . The lack of correlation between the mRNA levels and 318 peptide abundance in progenitor and sub-clone cells is potentially very informative. It has been 319 common practice to consider mRNA abundance as the major determinant of protein abundance, but 320 the many complicated and varied post-translational steps responsible for converting mRNA into 321 protein are frequently overlooked. Emerging evidence suggests that transcript abundance only 322 partially predicts protein abundance. Vogel & Marcotte (2012) reported that there is only around a 323 40% correlation between mRNA and protein abundance, which means that approximately 60% of 324 variations arise from a combination of post-transcriptional regulation and measurement noise. The 325 strongest contribution evidently comes from protein translation, and it has been proposed that 326 differences could purely be due to energy constraints within the gene expression system 327 (Schwanhausser et al., 2011). Protein synthesis actually consumes more than 90% of a cell's energy 328 but less than 10% is consumed by transcription, and so much less energy is required to transcribe 329 mRNA than to translate and process the actual protein. Enteroendocrine cells represent a system 330 which is required to respond quickly to external stimuli and Schwanhausser et al., (2011) found that 331 such systems are characterised by stable mRNA copies and unstable proteins, and classified these as 332 'translationally regulated genes'. For example, when two ferritin proteins are rapidly upregulated in 333 response to iron, this upregulation is not dependant on the generation of more mRNA but on dynamic insulin secretion in a cloned cell line but no significant change in mRNA expression and they suggested 336 this was due to vesicular release rather than transcriptional regulation of the GIP promoter. This adds 337 weight to the argument that translation of the protein is regulated more stringently than transcription. 338
There is some speculation that other homeostatic genes regulate themselves in a similar manner and 339 the proglucagon gene could certainly be categorised as homeostatic. GLP-1 plays an important role 340 in glucose homeostasis and responds rapidly to nutrient ingestion therefore it would seem 341 appropriate that it is regulated at the translational rather than transcriptional level. So it would appear 342 that translational regulation is potentially very important for the biosynthesis of these hormones and 343 it explains the startling discrepancy between the progenitor and sub-clone cell lines examined here. proinsulin mRNA pre-existent on the membrane-bound polysome in pancreatic islets (Itoh & 354 Okamoto, 1980) . Similar studies in enteroendocrine cells regarding incretin hormones have not yet 355 been carried out but given the similarities between GIP and insulin biosynthesis (Ramshur, Rull & Wice, 356 2002), it is not unreasonable to suggest a similar mechanism for incretin hormones. In general, it is 357 seems important to remember that mRNAs and proteins are information carriers of the cell. Their 358 degradation or translation can be an in-built timer controlling the persistence of genetic information 359 (Pedraza & Paulsson, 2008) . Sufficient quantities of peptide produced by the cell can trigger negative 360 feedback reducing mRNA transcription which is another reason to explain the lack of correlation in 361 this study. 362
Indeed, GIP mRNA and protein abundance did not correspond either. In this case the relationship was 363 reversed with pGIP/Neo having significantly fewer mRNA GIP transcripts, yet significantly greater 364 intracellular GIP. Both GLP-1 and GIP are post-translationally processed by PC3. Therefore it appears 365 that the pGIP/Neo expression vector in the sub-clone cells has preferred translation and processing of 366 GIP rather than GLP-1. The greater constitutive GIP producing status of the cells results in reduced 367 mRNA levels of GIP because this is more efficient for the cell. With this in mind, the default position order to ensure adequate supply of GIP should the cells be required to switch production.
1 and GIP processing this may suggest that this cell line has an enhanced ability to post-translationally 372 process peptides than the STC-1 cell line. In addition, we detected significantly greater gene 373 expression of the ubiquitin-conjugating enzyme E2D2 (E2D2) in pGIP/Neo compared with the STC-1 374 cell line. Ubiquitin enzymes determine protein turnover, regulation, molecular function and provide a 375 complex regulation of the proteome and the E2 enzymes have been ascribed a role in deciding the 376 'life or death' of a protein (van Wijk & Timmers, 2010). At the present time there is no evidence that 377 E2D2 influences the fate of any of the peptides discussed here, but we do note a correlation between 378 PC3 expression, E2D2 expression, and increased GIP production. The caveat here is that only mRNA 379 was measured for PC3 and E2D2 and the corresponding protein levels or enzyme activities have not 380 been assessed. 381
We observed a trend of higher intracellular PYY and CCK levels in pGIP/Neo compared with STC-1 but 382 this was not statistically significant. However, there were significantly more PYY mRNA transcripts in 383 pGIP/Neo, and in contrast, significantly fewer CCK mRNA transcripts. It has not been established 384 precisely how these prepropeptides are processed to their biologically active forms but prohormone 385 convertases are thought to be involved (Yoon & Beinfeld, 1997) . Once again the differences in 386 PYY/CCK expression did not reflect differences in PYY and CCK immunoreactivity (HCA), but it is 387 entirely possible that these peptide hormones are more tightly regulated at a translational level, 388 rather than at a transcriptional level. 389
The in-depth cell-by-cell analysis using the HCA also gave an interesting insight into the co-localisations 390 of four enteroendocrine hormones in both of these cell lines. Technical constraints meant that we 391 could not measure all four hormones simultaneously (four-channel fluorescent imaging, but with one-392 channel reserved for Hoechst nuclear staining). Therefore, hormones were measured in two sets of 393 triplets (i.e. GLP-1, GIP & PYY and GLP-1, GIP & CCK) with the two incretins serving as reference points. 394 HCA data clearly verify that the pGIP/Neo STC-1 cell line contains more cells with more GIP-395 immunoreactivity than the progenitor STC-1 cell line. There were not just increases in cells which were 396 exclusively GIP-immunoreactive but also an increase in the number of cells which were for three or more of the hormones. 417
As mentioned the percentage of cells containing some form of GIP immunoreactivity i.e. including low 418 (minus zero immunoreactivity), within range, or high increased from 65% in the progenitor cell line to 419 82% in pGIP/Neo. The percentage of cells with zero GIP immunoreactivity tended to be lower in 420 pGIP/Neo but was not significant. However, the percentage of pGIP/Neo cells with intense GIP 421 immunoreactivity was significantly increased, and the percentage with low GIP immunoreactivity 422 significantly decreased. This proves the utility of HCA in characterising novel cell lines by showing how 423 the pGIP/Neo population gives rise to more GIP peptide. 424
One potential limitation of the current study is that the two cell lines have different cell culture 425 medium requirements. The higher serum levels of STC-1 (17.5% FBS versus 10% FBS for GIP/Neo) could 426 potentially increase cell growth or cell density, which in turn could increase enteroendocrine 427 hormones levels. Neither our pilot studies (72h) nor the High Content Analysis studies (<24h) detected 428 any significant differences in the rate of cell proliferation between the two cell lines. Furthermore, it 429 should be mentioned that some hormones i.e. GLP-1 and GLP-2 actually decreased rather than 430 increased. Nonetheless, if future studies could harmonise the cell culture medium used for the two 431 cell lines this would minimise any confounding effect from this. 432 433 Metabolomic profiling of media (pre-culture versus cell-cultured) culture assessed nutrient utilisation 434 of the cell lines. Since the composition of the cell culture media differs between cell lines pairwise 435 statistical comparisons were not possible. However, metabolite profiling did reveal a number of similarities and differences in the nutrient utilisation/production of cell lines. At first glance the energy 437 requirements of the two cell lines appear broadly similar. Reductions in glucose in the media suggest 438 equivalent levels of glycolytic activity. Furthermore, another key source of cellular energy, glutamine, 439 was utilised to similar extent in both cell lines. A major difference between cell lines was that pGIP/Neo 440 cells had much greater propensity to utilise propionylcarnitine. Propionylcarnitine is a carrier of 441 propionate which enters the Kreb's cycle and contributes to cellular energy (Brevetti et al., 1997) . 442 443 Both cell lines appeared to produce substantial quantities of proline, which is not surprising given that 444 other cell lines have been reported to produce and release proline into the cell culture medium 445 (Genzel et al. 2004 ). Proline production apparently results from overflow metabolism of glutamine 446 which ends in excess production of ammonium and the amino acids alanine, proline, ornithine, 447 asparagine, glutamate, serine and glycine (Ljunggren and Häggström, 1992) . We observed significant 448 increases in alanine and serine in both cell lines and in pGIP/Neo cell-cultured media glycine was also 449 increased. Closer examination of proline, alanine, serine and glycine suggests that both cell lines, but 
Conclusion 462
In conclusion these studies provide detailed profiling and characterisation of the novel pGIP/Neo cell 463 line. Our data show for the first time that production and secretion of proglucagon peptides (GLP-1 464 and GLP-2) are significantly decreased in pGIP/Neo compared to the progenitor STC-1 cell line. 465 Furthermore, we have provided substantial confirmatory evidence that GIP production is increased in 466 pGIP/Neo cells with a significantly greater percentage of pGIP/Neo cells having high GIP 467
immunoreactivity. However, the most surprising observation was that observed peptide levels were cell line, the progenitor STC-1 cells had many more GIP mRNA transcripts. The same discrepancy was found for GLP-1 production and proglucagon transcripts than the sub-clone pGIP/Neo cells. Firstly 471 this exposes the pitfall of interpreting increased transcript levels as leading to increases in incretin 472 peptides but most interestingly it provides the first evidence suggesting that enteroendocrine 473 hormones may be produced on translationally regulated genes. Metabolomic profiling highlighted 474 that in many respects the utilisation and release of many nutrients (including glucose) from STC-1 and 475 pGIP/Neo cells do not differ. However, pGIP/Neo cells utilise proportionately more 476 proprionylcarnitine from culture media suggesting altered energy metabolism. 
